WASHINGTON, Dec. 11 -- Food and Drug Administration has issued a notice called: Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information.
The notice was published in the Federal Register on Dec. 11 by Lowell M. Zeta, Acting Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing a request for information from interested parties and the public to share their perspectives with FDA on testosterone replacement therapy for men. The Agency intends to use the information submitted to help inform considerations related to testosterone therapy for men.
For more information, contact Renu Lal, Divisi...